Using innovative models to assess TAM functions in 3D cell culture and mice, we demonstrated that upstream heme signaling through NRF2 reprograms macrophages to fuel cancer growth, invasion, metastasis, and resistance to immunotherapy. Here, NFE2L2 is linked to cancer.